人工智能在乳腺影像中的应用
本文综述了计算机辅助检测(CAD)系统与人工智能在乳腺影像中的应用现状与未来机遇。传统CAD采用基于规则的方法,已显示会对部分放射科医师的判读表现产生不利影响并增加召回率;深度学习方案在数字乳腺摄影DREAM挑战赛中胜出,基于深度学习的AI-CAD系统已用于数字乳腺断层摄影、超声和MRI,但对比增强能谱乳腺摄影领域尚存市场空白,临床落地需贴近真实场景的验证、成本效果评估,并应纳入可解释AI以符合《通用数据保护条例》。
要点
- 传统乳腺X线筛查CAD基于规则方法,已显示会对部分放射科医师判读表现产生不利影响并增加召回率。
- 数字乳腺摄影DREAM挑战赛提供64万张乳腺摄影图像,获胜方案采用深度学习自动层级特征学习与卷积神经网络。
- 数字乳腺断层摄影已有专用AI-CAD系统(iCAD的PowerLook Tomo Detection、ScreenPoint Medical的Transpara),对比增强能谱乳腺摄影AI-CAD工具尚存市场空白。
核心结论
- AI-CAD工具临床落地需在模拟真实场景中测试以证明其临床环境中的实用性,需大而具代表性的数据集评估读片者与工具的交互,并应开展成本效果评估与大规模可行性研究以确认无意外后果。
- AI-CAD系统应纳入可解释AI以符合欧盟《通用数据保护条例》(GDPR)。
研究设计与样本
- 综述类文章,回顾CAD系统与人工智能在乳腺影像中应用的当前局限与未来机遇,未报告检索范围与纳入文献数量。
- 数字乳腺摄影DREAM挑战赛为多学科协作,向参赛团队提供64万张乳腺摄影图像,以帮助降低乳腺癌筛查中的假阳性率。
诊断标准与关键数值
- 传统乳腺X线筛查CAD采用基于规则的方法,将领域知识融入手工特征,再以经典机器学习技术作为分类器。
- 首个商用CAD系统ImageChecker M1000依赖计算机视觉技术进行模式识别。
- 数字乳腺摄影DREAM挑战赛获胜方案利用深度学习自动层级特征学习能力并使用卷积神经网络。
- 数字乳腺断层摄影的专用AI-CAD系统包括iCAD的PowerLook Tomo Detection与ScreenPoint Medical的Transpara。
- 其他AI-CAD系统聚焦超声与磁共振成像等乳腺诊断技术,对比增强能谱乳腺摄影AI-CAD工具尚存市场空白。
临床应用与阅片要点
- 传统CAD系统已显示会对部分放射科医师的判读表现产生不利影响并增加召回率。
- AI-CAD工具的临床实施需在模拟真实场景中测试,以证明其在临床环境中的实用性。
- AI-CAD工具的评估需大而具代表性的数据集,并评估读片者与工具的交互。
- AI-CAD工具应开展成本效果评估,并开展大规模可行性研究以确保无意外后果。
- AI-CAD系统应纳入可解释AI以符合欧盟《通用数据保护条例》(GDPR)。
局限性
- 传统CAD系统已显示会对部分放射科医师的判读表现产生不利影响并增加召回率。
- 对比增强能谱乳腺摄影AI-CAD工具尚存市场空白。
- AI-CAD工具临床实施需在模拟真实场景中测试以证明其实用性。
- AI-CAD系统应纳入可解释AI以符合欧盟《通用数据保护条例》(GDPR)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This article reviews current limitations and future opportunities for the application of computer-aided detection (CAD) systems and artificial intelligence in breast imaging. Traditional CAD systems in mammography screening have followed a rules-based approach, incorporating domain knowledge into hand-crafted features before using classical machine learning techniques as a classifier. The first commercial CAD system, ImageChecker M1000, relies on computer vision techniques for pattern recognition. Unfortunately, CAD systems have been shown to adversely affect some radiologists' performance and increase recall rates. The Digital Mammography DREAM Challenge was a multidisciplinary collaboration that provided 640,000 mammography images for teams to help decrease false-positive rates in breast cancer screening. Winning solutions leveraged deep learning's (DL) automatic hierarchical feature learning capabilities and used convolutional neural networks. Start-ups Therapixel and Kheiron Medical Technologies are using DL for breast cancer screening. With increasing use of digital breast tomosynthesis, specific artificial intelligence (AI)-CAD systems are emerging to include iCAD's PowerLook Tomo Detection and ScreenPoint Medical's Transpara. Other AI-CAD systems are focusing on breast diagnostic techniques such as ultrasound and magnetic resonance imaging (MRI). There is a gap in the market for contrast-enhanced spectral mammography AI-CAD tools. Clinical implementation of AI-CAD tools requires testing in scenarios mimicking real life to prove its usefulness in the clinical environment. This requires a large and representative dataset for testing and assessment of the reader's interaction with the tools. A cost-effectiveness assessment should be undertaken, with a large feasibility study carried out to ensure there are no unintended consequences. AI-CAD systems should incorporate explainable AI in accordance with the European Union General Data Protection Regulation (GDPR).
引用
- Le EPV, Wang Y, Huang Y, et al. Artificial intelligence in breast imaging. Clin Radiol. 2019. PMID: 30898381. doi:10.1016/j.crad.2019.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。